Jian Fan/iStock via Getty Images
By Jennifer Nash
Our global markets watchlist tracks nine prominent indexes from economies around the world. The list includes the S&P 500 from the United States, TSX from Canada, the FTSE 100 from England, the DAXK from Germany, the
The S&P 500 ended lower on Tuesday, weighed down by losses in Micron Technology and other chipmakers due to mounting doubts about the sustainability of Wall Street’s AI-driven rally. Chip stocks in Asia and the United States dropped after memory chip giant Samsung Electronics’ blowout earnings report failed to satisfy investors with sky-high expectations. Micron…
Income-tax returns: The income-tax department has released excel utility of its ITR-1 (Sahaj), ITR-2, ITR-3, and ITR-4 (Sugam) online forms for financial year 2025-26 i.e. assessment year 2026-27 and notified all ITR forms 1-5 for this tax year (FY26 / AY27). Notably, availability of excel utility means that you can prepare your returns offline before…
The stock market has been on a strong run, but it’s not clear how long it will — or can — last. With elevated valuations, persistent inflation, shifting market leadership and AI enthusiasm reaching a fever pitch, who could blame investors for asking the uncomfortable questions: Is this rally built on solid ground? Or is…
Jemal Equities has landed a $27 million commercial mortgage-backed securities loan for 1750 H Street NW in Washington, D.C., Commercial Observer has learned. The loan, from Citibank and arranged by Meridian Capital Group, follows the July 2025 purchase of the building by Jemal for $28.5 million. At the time, the 123,000-square-foot office building was almost…
Keir Starmer vowed not to touch the triple lock, a system that promises to increase the state pension each April by either the rate of inflation, average earnings growth or 2.5% – whichever is highest. The triple lock guarantee saw over 12 million pensions receive a state pension boost in April, as it increased by…
HANGZHOU, China, July 8, 2026 /PRNewswire/ — On July 8, the study of Betta’s ensartinib as postoperative adjuvant therapy for patients with stage IB–IIIB (T3N2M0) ALK-positive non-small cell lung cancer (NSCLC), known as the ELEVATE study, was published online in full in The New England Journal of Medicine (NEJM; Impact Factor 84.5), a world-leading medical journal….